SEC Filing Summary: Oculus Innovative Sciences, Inc.
Business Context and Reporting Period
This Form 8-K was filed by Oculus Innovative Sciences, Inc. (not Sonoma Pharmaceuticals, Inc.) on November 5, 2012. The report addresses a specific corporate event regarding the company's listing status on the NASDAQ stock exchange.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. The report focuses exclusively on regulatory compliance status rather than financial performance data.
Material Changes
On November 5, 2012, the Company announced its belief that it has obtained compliance with the minimum stockholders' equity requirement of the NASDAQ Listing Rules. This represents a material change in the company's regulatory standing regarding its stock exchange listing.
Guidance, Outlook, and Risks
The filing contains forward-looking statements regarding the Company's belief in its compliance status. Management notes that actual outcomes may differ materially due to risks and uncertainties discussed in the Company's Annual Report on Form 10-K. The Company does not undertake an obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the official confirmation of NASDAQ compliance from the exchange.
- Review the full text of the press release furnished as Exhibit 99.1.
- Consult the most recent Form 10-K for detailed financial metrics and risk factors.
- Confirm the company's current stockholders' equity balance to ensure sustained compliance.